Skip to content

Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02783066
Enrollment
16
Registered
2016-05-26
Start date
2016-01-31
Completion date
2019-10-30
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer, Offloading

Brief summary

Diabetic foot ulceration (DFU) is a common and largely preventable complication of diabetes. While most of these ulcers can be treated successfully, some will persist and become infected. Ultimately, nearly one fifth of patients with infected lower-extremity diabetic ulcers will require amputation of the affected limb, resulting in staggering costs for both the patient and the healthcare system. Prevention by identifying people at higher risk is key for better clinical management of such patients. It is not uncommon for patients suffering from diabetes to have concomitant lower extremity edema or venous insufficiency and they subsequently may benefit from graduated compression. However, because of the common association of peripheral arterial disease (PAD) in patients with diabetes, most clinicians are reluctant to apply compressive dressings in fear of exacerbating the symptoms of PAD and possibility of gangrene. A novel low voltage, battery powered medical device, PulseFlow DF® (The Diabetic Boot Company, Ltd. UK) has endeavored to assist in the treatment of Diabetic Foot Ulcers. The device provides hybrid functionality i.e. mobile air bladder pump at plantar arch and offloading boot. The air bladder inflates to 160 mmHg for approx. 1 second then deflates back to atmospheric pressure, allowing the plantar vessels sufficient time to refill. The offloading boot design holds the foot and lower leg in a position that reduces shear and friction forces and provides a reduction in plantar pressure. The PulseFlow DF is designed to record how many hours of blood pumping it has delivered. This data will be downloaded at each clinic visit. The boot cannot pump blood around the participant's foot unless fitted correctly and the battery is charged up overnight. The purpose of this study is to conduct an interventional study study with N=15 diabetic subjects with active foot ulcers to assess whether PulseFlow foot compression device can help improve lower extremity perfusion, whilst improving balance and spatio-temporal parameters of gait. The key goals of the proposed project are to test whether a specially designed compression device can improve lower extremity perfusion, whilst also simultaneously improving the balance and walking performance. Investigators envision the use of this specially designed offloading device with compression capability will help reduce the incidence of diabetic foot ulcers in high-risk diabetic patients. In addition, investigators assumed the proposed device might enhance daily physical activity as well as walking performance. Investigators will conduct a prospective clinical study to validate these hypotheses. Potential changes in walking and spontaneous daily physical activities will be assessed using validated technologies that include walking analyzer system, balance assessment using body worn sensors, and computerized pressure insoles.

Interventions

DEVICEOffloading boot: PulseFlow

A new offloading boot, which may enhance balance, gait, and lower extremity blood flow

Sponsors

The Diabetic Boot Company
CollaboratorINDUSTRY
Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18- 80 years old * type II diabetes with active plantar ulcer,

Exclusion criteria

* Non-ambulatory or unable to stand without help or walk a distance of at least 6 feet without assistance * Plantar ulcer on arch of the foot * Patients with PAD (Ankle Brachial Index \< 0.5) * Acute foot fracture * Heart failure * Pregnant women * Patients on immunosuppressive drugs * Participation in an interventional study in the last 30 days * Major amputation * Patients unable or unwilling to participate in all procedures and follow-up evaluations.

Design outcomes

Primary

MeasureTime frameDescription
Lower Extremity Perfusion Change From Baseline to 4 Weeksbaseline and 4 weeksSkin perfusion measured in the ankle using Sensilase device. To measure Skin Perfusion Pressure (SPP), a pressure cuff is first automatically inflated to occlude arterial bed blood flow; this is verified by PAD-IQ by determining when perfusion has stopped. The pressure is then automatically released at a controlled rate while the cuff pressure and skin perfusion are measured. A graph displays pressure and perfusion during cuff deflation and indicates the pressure at which skin perfusion is found to return.
Gait Speed Difference Between Pulseflow Offflaoding and Standard Offloadingbaselinethe quality of walking while wearing Pulseflow offflaoding compared to standard offloading

Secondary

MeasureTime frameDescription
Stride Length Difference Between Pulseflow Offflaoding and Standard Offloadingbaselinethe quality of walking while wearing Pulseflow offflaoding compared to standard offloading
Limp Difference Between Pulseflow Offflaoding and Standard OffloadingbaselineLimp: the difference in stance percent between right and left feet
Peak Swing Angular VelocitybaselineAngular Velocity of leg swing during walking for each side
Adherence4 weeksadherence to wear offloading boot by downloading from the study device to a specific developed software. The measure is the mean number of minutes the offloading boot was worn for over the course of 4 weeks
Center of Mass Sway While Wearing Standard Offloading BootbaselineCenter of Mass (COM) sway measured by wearable inertial sensors
Center of Mass Sway While Wearing Pulseflow Offloadingbaselinecenter of mass sway measured by a wearable inertial sensor
Peak Forefoot Pressurebaseline
Ratio of Propulsion Time to Stance TimebaselinePropulsion time and stance time for each stride is caulcated by wearable sensors. The measure is ratio of propulsion time to stance time as percentage value.
Wound Size Change From Baseline to 4 Weeks.baselineand and 4 weeksmeasuring the size of the wound (W, L,H)

Countries

United States

Participant flow

Participants by arm

ArmCount
PulseFlow Group
Eligible subjects will try a new offloading boot for 4 weeks Offloading boot : PulseFlow: A new offloading boot, which may enhance balance, gait, and lower extremity blood flow
16
Total16

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawal by Subject13

Baseline characteristics

CharacteristicPulseFlow Group
Age, Continuous57.4 years
STANDARD_DEVIATION 15.3
Body mass index (BMI)31.3 kg/m^2
STANDARD_DEVIATION 5.9
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
6 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 3
other
Total, other adverse events
0 / 3
serious
Total, serious adverse events
0 / 3

Outcome results

Primary

Gait Speed Difference Between Pulseflow Offflaoding and Standard Offloading

the quality of walking while wearing Pulseflow offflaoding compared to standard offloading

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupGait Speed Difference Between Pulseflow Offflaoding and Standard OffloadingWalking speed with Pulse flow offloading0.59 m/sStandard Deviation 0.2
PulseFlow GroupGait Speed Difference Between Pulseflow Offflaoding and Standard OffloadingWalking speed with standard offloading0.57 m/sStandard Deviation 0.2
Primary

Lower Extremity Perfusion Change From Baseline to 4 Weeks

Skin perfusion measured in the ankle using Sensilase device. To measure Skin Perfusion Pressure (SPP), a pressure cuff is first automatically inflated to occlude arterial bed blood flow; this is verified by PAD-IQ by determining when perfusion has stopped. The pressure is then automatically released at a controlled rate while the cuff pressure and skin perfusion are measured. A graph displays pressure and perfusion during cuff deflation and indicates the pressure at which skin perfusion is found to return.

Time frame: baseline and 4 weeks

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupLower Extremity Perfusion Change From Baseline to 4 Weeksulcerated167 percentage of baseline perfusionStandard Deviation 71
PulseFlow GroupLower Extremity Perfusion Change From Baseline to 4 Weekscontralateral75 percentage of baseline perfusionStandard Deviation 51
Secondary

Adherence

adherence to wear offloading boot by downloading from the study device to a specific developed software. The measure is the mean number of minutes the offloading boot was worn for over the course of 4 weeks

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
PulseFlow GroupAdherence6791 minutesStandard Deviation 4914
Secondary

Center of Mass Sway While Wearing Pulseflow Offloading

center of mass sway measured by a wearable inertial sensor

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupCenter of Mass Sway While Wearing Pulseflow Offloadingdouble stance with eyes open0.14 cm^2Standard Deviation 0.06
PulseFlow GroupCenter of Mass Sway While Wearing Pulseflow Offloadingdouble stance with eyes closed0.46 cm^2Standard Deviation 0.34
PulseFlow GroupCenter of Mass Sway While Wearing Pulseflow Offloadingtandem stance with eyes open0.29 cm^2Standard Deviation 0.13
PulseFlow GroupCenter of Mass Sway While Wearing Pulseflow Offloadingtandem stance with eyes closed0.46 cm^2Standard Deviation 0.2
Secondary

Center of Mass Sway While Wearing Standard Offloading Boot

Center of Mass (COM) sway measured by wearable inertial sensors

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupCenter of Mass Sway While Wearing Standard Offloading Bootdouble stance with eyes open0.18 cm^2Standard Deviation 0.04
PulseFlow GroupCenter of Mass Sway While Wearing Standard Offloading Bootdouble stance with eyes closed0.36 cm^2Standard Deviation 0.04
PulseFlow GroupCenter of Mass Sway While Wearing Standard Offloading Boottandem stance with eyes open0.38 cm^2Standard Deviation 0.28
PulseFlow GroupCenter of Mass Sway While Wearing Standard Offloading Boottandem stance with eyes closed0.74 cm^2Standard Deviation 0.16
Secondary

Limp Difference Between Pulseflow Offflaoding and Standard Offloading

Limp: the difference in stance percent between right and left feet

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupLimp Difference Between Pulseflow Offflaoding and Standard Offloadingstandard offlaoding4.38 percentageStandard Deviation 2.96
PulseFlow GroupLimp Difference Between Pulseflow Offflaoding and Standard OffloadingPulseflow offlaoding2.99 percentageStandard Deviation 2.56
Secondary

Peak Forefoot Pressure

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupPeak Forefoot Pressureoffloaded side of pulseflow offloading147.0 PaStandard Deviation 114.3
PulseFlow GroupPeak Forefoot Pressurecontralateral side of pulseflow offloading196.9 PaStandard Deviation 84.4
PulseFlow GroupPeak Forefoot Pressureoffloaded side of standard offloading168.7 PaStandard Deviation 156.9
PulseFlow GroupPeak Forefoot Pressurecontralateral side of standard offloading276.7 PaStandard Deviation 105.7
Secondary

Peak Swing Angular Velocity

Angular Velocity of leg swing during walking for each side

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupPeak Swing Angular Velocityoffloaded side of standard offloading172.53 degree per secondStandard Deviation 56.85
PulseFlow GroupPeak Swing Angular Velocitycontralateral side of standard offloading178.49 degree per secondStandard Deviation 60.31
PulseFlow GroupPeak Swing Angular Velocityoffloaded side of pulseflow offloading191.72 degree per secondStandard Deviation 50.52
PulseFlow GroupPeak Swing Angular Velocitycontralateral side of pulseflow offloading166.77 degree per secondStandard Deviation 81.65
Secondary

Ratio of Propulsion Time to Stance Time

Propulsion time and stance time for each stride is caulcated by wearable sensors. The measure is ratio of propulsion time to stance time as percentage value.

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupRatio of Propulsion Time to Stance Timeoffloaded side of standard offloading55 percentage of stance timeStandard Deviation 4
PulseFlow GroupRatio of Propulsion Time to Stance Timecontralateral side of standard offloading60 percentage of stance timeStandard Deviation 8
PulseFlow GroupRatio of Propulsion Time to Stance Timeoffloaded side of pulseflow offloading67 percentage of stance timeStandard Deviation 4
PulseFlow GroupRatio of Propulsion Time to Stance Timecontralateral side of pulseflow offloading62 percentage of stance timeStandard Deviation 7
Secondary

Stride Length Difference Between Pulseflow Offflaoding and Standard Offloading

the quality of walking while wearing Pulseflow offflaoding compared to standard offloading

Time frame: baseline

ArmMeasureGroupValue (MEAN)Dispersion
PulseFlow GroupStride Length Difference Between Pulseflow Offflaoding and Standard Offloadingstandard offlaoding0.85 mStandard Deviation 0.2
PulseFlow GroupStride Length Difference Between Pulseflow Offflaoding and Standard OffloadingPulseflow offlaoding0.88 mStandard Deviation 0.3
Secondary

Wound Size Change From Baseline to 4 Weeks.

measuring the size of the wound (W, L,H)

Time frame: baselineand and 4 weeks

ArmMeasureValue (MEAN)Dispersion
PulseFlow GroupWound Size Change From Baseline to 4 Weeks.-60 percentage of baseline wound areaStandard Deviation 37

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026